Addition of enoximone to adrenergic agents in the management of severe heart failure

OBJECTIVETo assess the hemodynamic effects of the addition of small bolus doses of the phos-phodiesterase inhibitor enoximone to adrenergic therapy in patients with severe heart failure. DESIGNOpen label, prospective study. SETTINGMultidisciplinary department of intensive care in a university academ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 1992-08, Vol.20 (8), p.1102-1106
Hauptverfasser: VINCENT, JEAN-LOUIS, LÉON, MARC, BERRÉ, JACQUES, MÉLOT, CHRISTIAN, KAHN, ROBERT J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVETo assess the hemodynamic effects of the addition of small bolus doses of the phos-phodiesterase inhibitor enoximone to adrenergic therapy in patients with severe heart failure. DESIGNOpen label, prospective study. SETTINGMultidisciplinary department of intensive care in a university academic hospital. PATIENTSTwelve surgical patients after cardiac surgery and ten medical patients with ischemic or dilated cardiomyopathy who had signs of altered tissue perfusion associated with a low cardiac index (
ISSN:0090-3493
1530-0293
DOI:10.1097/00003246-199208000-00006